Your email has been successfully added to our mailing list.

×
0.00545585068198137 0.00545585068198137 0.00430725053840635 0.00430725053840635 0.00430725053840635 0.00592246949030878 0.00573582196697777 0.0057430007178751
Stock impact report

LEO Pharma's eczema cream gains MHRA marketing authorisation [Yahoo! Finance]

JAPAN TOBACCO UNSP/ADR (JAPAY) 
NASDAQ:AMEX Investor Relations: gungho.co.jp/en/ir
Company Research Source: Yahoo! Finance
kinase (JAK) inhibitor, Anzupgo (delgocitinib) 20mg/g cream, to treat chronic hand eczema (CHE) in Britain. The approval enables the treatment of adults with moderate to severe CHE when topical corticosteroids are inadequate or inappropriate. LEO Pharma UK and Ireland vice-president and general manager Leanne Walsh stated: “Today's MHRA approval of delgocitinib cream marks a significant milestone for adults in Great Britain living with moderate to severe chronic hand eczema. “This approval offers a new treatment paradigm and demonstrates our commitment to addressing the unmet needs of people living with skin conditions.” The cream targets the JAK-STAT signalling pathway involved in CHE pathogenesis. The condition is marked by skin barrier dysfunction, inflammation and changes in the skin microbiome. The current approval of delgocitinib cream adds to its existing authorisations in the European Union and Switzerland for the same indication. LEO Pharma obtained exclusive deve Show less Read more
Impact Snapshot
Event Time:
JAPAY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for JAPAY alerts
Opt-in for
JAPAY alerts

from News Quantified
Opt-in for
JAPAY alerts

from News Quantified